Showing results (171-180 of 250) with videos related to

Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|November 24, 2025
Chronic alcohol intake elicits distinct multi-omic profiles in the liver versus skeletal muscle of miceCraig R G Willis, Muni Swamy Ganjayi, Austin M Brown, et al.
Alcohol, Clinical & Experimental Research|January 30, 2026
Comparative multi-omics in female mice reveals tissue-specific vulnerabilities to chronic alcohol intakeCraig R G Willis, Muni Swamy Ganjayi, Austin M Brown, et al.
Journal of the American Medical Directors Association|June 24, 2021
Assessing Additional Characteristics of Muscle Function With Digital Handgrip Dynamometry and Accelerometry: Framework for a Novel Handgrip Strength ProtocolRyan McGrath, Grant R Tomkinson, Brian C Clark, et al.
JBMR Plus|May 1, 2024
Fracture discrimination capability of ulnar flexural rigidity measured via Cortical Bone Mechanics Technology: study protocol for The STRONGER StudyStuart J Warden, Andrew Dick, Janet E Simon, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 26, 2026
Characterization of sensory nerve conduction abnormalities at the time of ALS diagnosisArsh Ketabforoush, W David Arnold, Armin Ariaei, et al.
Neurobiology of Disease|April 24, 2012
Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in miceAmit K Srivastava, Samantha R Renusch, Nicole E Naiman, et al.
Neurology|July 16, 2017
Open-label trial of ranolazine for the treatment of myotonia congenitaW David Arnold, David Kline, Alan Sanderson, et al.
Muscle & Nerve|June 5, 2013
Ethambutol toxicity exacerbating the phenotype of CMT2A2Ekokobe Fonkem, Monica A Skordilis, Elaine M Binkley, et al.
Muscle & Nerve|November 4, 2018
Open-label trial of ranolazine for the treatment of paramyotonia congenitaSamantha Lorusso, David Kline, Amy Bartlett, et al.
Clinical Drug Investigation|June 23, 2024
Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis TreatmentArsh Ketabforoush, Faezeh Faghihi, Fereshteh Azedi, et al.
Pageof 25